Glaucoma

Examine the anterior segment for risk factor identification and early diagnosis.

Justin Schweitzer, OD, shares key highlights from his presentation titled, "The OD's Role in the Management of MIGS in 2022," where he explores earlier intervention for glaucoma patients.

Vin Dang, OD, FAAO, and Jacob Lang, OD, FAAO, speak on the highlights and key takeaways from their AOA 2022 lecture titled "Ocular surface preservation for the glaucoma patient."

Investigators from the Sun Yay-Sen University in Guangzhou have created a theranostic device that targets sensing rising fluid pressures within the eye to automatically deliver medication for a glaucoma patient.

Optometrists can play an important role in early detection, earlier surgical referral to experienced skillful surgeons, surveillance, and follow-up care for glaucoma patients.

This far-less-understood option can fill multiple needs for a practice.

Four patients present with previously undiagnosed conditions.

Research to Prevent Blindness will launch the RPB/David L. Epstein Career Advancement Award in Glaucoma Research, sponsored by Aerie Pharmaceuticals.

Routine eye exam catches juvenile-onset open-angle glaucoma.

The National Institute for Health and Care Excellences announced SLT as the new primary form of glaucoma intervention.

Certain foreign online pharmacies may be scamming this patient base

SECO hosted its 2022 annual meeting March 9-13 at the Ernest N. Morial Convention Center with a LIVE CE virtual meeting available to online attendees.

Mitch Ibach, OD, FAAO and Michael Greenwood, MD review their SECO 2022 presentation on comanaging glaucoma

Lee Peplinski, OD, FAAO, emphasizes the importance of interventional care in patients with glaucoma.

Other factors, besides IOP, can contribute to glaucomatous optic nerve damage

See our latest poll results

New platform has potential to overcome challenges of legacy technology

Sustained-release injectables may be key to addressing the greatest obstacles in glaucoma.

Oluwatosin Smith, MD, reviews different applications of minimally invasive glaucoma surgeries (MIGS) to find the best option, with the best outcome, for every patient.

Risk factors take priority

The future is sustained-release injectables

Andrew G. Iwach, MD, shares a few key highlights from his presentation regarding trend challenges of glaucoma.

Oluwatosin U. Smith, MD, speaks shares the highlights of her presentation exploring remote monitoring of glaucoma and the future of virtual care on the whole.

Industry keenly focused on innovations

Ranya Habash, MD, shares a sneek peek of her New Horizions keynote speech on "The future of eye care: science fiction to science fact," during the 2022 Glaucoma 360 meeting.